Scientific Programme


Tuesday • 29 March 2016

MAIN HALL (Amphitheater)
12:30-18:15 WPA Intersectional Educational Track
12:30-12:45 A. Javed (United Kingdom / Pakistan) & T.G. Schulze (Germany / USA): Introduction
12:45-13:30
V. Kovess: Psychiatric epidemiology
13:30-13:45 Intermission
13:45-14:30
A. Javed (United Kingdom / Pakistan): Psychiatric rehabilitation
14:30-15:15
T.G. Schulze (Germany / USA): Psychiatric genetics
15:15-15:45 Coffee Break
15:45-16:30
C. Ziegler (Germany) & K. Domschke (Germany): Psychiatric epigenetics
16:30-17:15 V. Kovess: Psychiatry and public health
17:15-17:30 Intermission
17:30-18:15 N. Sartorius (Switzerland): Challenges to Psychiatry 2016
18:15-19:00
 OPENING SESSION
Welcome Addresses - Michelle Tansella Award Ceremony
Wednesday • 30  March 2016

MAIN HALL
(Amphitheater)
PARALLEL HALL
(Alzheimer Saal)
09:00-11:00 SESSION 1: Epidemiology and Genetics
Chairs: P. Falkai (Germany), N. Sartorius (Switzerland)

  • K. Merikangas (USA): Retrospective and prospective studies  
  • T.G. Schulze (Germany): An update on psychiatric genetics  
  • E. Karam (Lebanon): A framework for genetic and epigenetic studies of trauma: experiences from the Middle East  
  • P. Appelbaum (USA): Public health and psychiatric genetics: the ethical implications 
 
11:00-11:30 Coffee Break
11:30-13:30
SESSION 2: Life perspectives: Input of cohorts
Chairs: I. Skoog (Sweden), T. Brugha (United Kingdom)

  • S. Sullivan (United Kingdom): ALSPAC: psychosis, depression and observational epidemiology
  • H. Jones (United Kingdom): Investigating phenotypic manifestation of genetic risk for schizophrenia in the general population using ALSPAC
  • H. Sallis (United Kingdom): ALSPAC and depression: using Mendelian randomisation to investigate causality
  • K. Keyes (USA): Cross-generational methods to elucidate cohort effects in psychiatric disorders
 
 13:30-15:00  Intermission (lunch on your own)
 15:00-15:30 ORAL PRESENTATIONS SESSION 1: Mental health services research
Chairs: R. Bruffaerts (Belgium),
P. Qin (Norway)

T. Brugha (United Kingdom):
OP01 │ Cost-effectiveness of health visitor training for postnatal depression: a randomised controlled trial

M.S. Burrone (Argentina):
OP02 │ Study of mental health disorders among care-seekers in primary health care centers in Cordoba, Argentina: first link aimed at strengthening the strategies of public policies in mental health
 15:30-17:00  Symposium 1: Depression’s heterogeneity: what do large epidemiology cohorts teach us?
Chairs: K. Merikangas (USA),
W. Maier (Germany)
       
  • S. Meier (Denmark):  Increased mortality among persons with anxiety disorders and depression: a nationwide study
  • F. Lamers (the Netherlands): Atypical and melancholic depression and their relevance for biomarkers and genetic research
  • Y. Milaneschi (the Netherlands): Staging of depression: a useful endeavor in psychiatric research?
  • C. Vandeleur (Switzerland): Depression characteristics as predictors of metabolic diseases and inflammatory markers
 Symposium 2: Cognitive disorders: a challenge of aging societies
Chairs: S.G. Riedel-Heller (Germany), J.L. Wang (Canada)

  • T. Luck (Germany): Prevalence of DSM-5 Mild Neurocognitive Disorder in dementia-free older adults – Results of the population-based LIFE-Adult-Study
  • F.S. Then (Germany): Interactions between APOE genotype and lifestyle factors on cognitive functioning: results of the health study of the Leipzig research center for civilization diseases (LIFE)
  • A. Zettergren (Sweden): The Alzheimer gene APOE is related to physical performance in old age
  • D. Gaysina (United Kingdom): Adverse childhood experiences and emotional and cognitive problems in later life: genetic contribution to risk and resilience
17:00-17:30
 Coffee Break
 17:30-19:00 Poster Session (POSTER AREA)

PP01 | E. Ando (Japan): The association of pet ownership and depression among the older Japanese adults: are dogs good friends with older?

PP02 | L. Aschan (United Kingdom): A prospective study of the association between mental-physical comorbidity and mental health service utilisation in a community sample

PP03 | W.-J. Chou (Taiwan): Self-esteem and its correlates among adolescents with Attention-Deficit/Hyperactivity Disorder

PP04 | L. Flatau (Germany): The “Right Not to Know”: a survey of patients, medical health care professionals, and the general population

PP05 | J. Kalman (Germany): Effects of schizophrenia polygenic risk scores on age at onset and premorbid psychosocial functioning in bipolar disorder

PP06 | H. Liu (USA): Generational differences in depression among Asian Americans: untangling the 1.5 generation

PP07 | T. Luck (Germany): Incident subjective memory complaints and the risk of subsequent dementia

PP08 | B. O'Donoghue (Australia): Neighbourhood characteristics and the incidence of First Episode Psychosis (FEP) and Duration of Untreated Psychosis (DUP)

PP09 | S. Roehr (Germany): Subjective cognitive decline is persistently associated with lower health-related quality of life in cognitively unimpaired elderly – Results from the longitudinal German study on Ageing, Cognition and Dementia in Primary Care (AgeCoDe)

PP10 | S. Tosato (Italy): The influence of recent stressful events and genetic susceptibility on the onset of first episode psychosis: data from the PICOS and the GET UP Projects

PP11 | Maria Carmen Viana (Brazil): The role of religiosity and social support on depression in the adult general population of Sao Paolo Metropolitan Area, Brazil
Thursday • 31 March 2016

MAIN HALL
(Amphitheater)
 PARALLEL HALL
(Alzheimer Saal)
09:00-11:00 SESSION 3: Physical comorbidities
Chairs: A. Roest (The Netherlands),
E. Karam (Lebanon)

  • N. Sartorius (Switzerland): Comorbidity of depression and diabetes: a worldwide approach 
  • R. Jenkins (United Kingdom): Mental disorders, malaria and immunity in Kenya
  • B. Löwe (Germany): Effectiveness of  a stepped-care network for somatoform disorders (Sofu-Net): a controlled study
  • A. Roest (The Netherlands): Disentangling the association between fear and distress disorders with subsequent onset of heart disease using a temporal perspective
  • M. Vestergaard (Denmark):  The effect of mental health on heart disease using bereavement as a natural experiment
  • M.C. Viana (Brazil): Prior mental disorders and subsequent onset of chronic back or neck pain: findings from 19 countries
 
11:00-11:30 Coffee Break  
11:30-12:00 Lecture
Chair: V. Kovess (France)

S. Galea (USA): Prioritising for better health. Rethinking our public health genetics research paradigm
12:00-14:00 Intermission (lunch on your own)
  
14:00-15:45 ORAL PRESENTATIONS SESSION 2: Prevalences and incidences around the globe (14:00-15:30)
Chairs: R. Jenkins (United Kingdom),
M. Vestergaard (Denmark)

A.M.S. Al-Ansari (Bahrain):
OP03 │ Characteristics of child and adolescent population visiting a public child and adolescent psychiatric clinic in Bahrain: a 30-years comparative analysis

N.F. Hashimzade (Azerbaijan):
OP04 │ Prevalence of mental disorders among children in the city of Baku, Azerbaijan

Y. Huang (China):
OP05 │ Descriptive epidemiological study of mental disabilities in China

P. Mortier (Belgium):
OP06 │ Comorbid psychopathological symptoms and suicidality among college students

K. Beesdo-Baum (Germany):
OP07 │ Incidence of anxiety, mood and substance use disorders in the first three decades of life as a function of familial liability: evidence for specificity

A. Mihai (Romania):
OP08 │ The epidemiology of depression in adult population in Romania – A cross sectional design 		ORAL PRESENTATIONS SESSION 3:
Risk, prediction, and biomarkers
Chairs: T.G. Schulze (Germany),
R. Kohn (USA)

J.L. Wang (Canada):
OP09 │ Development and validation of a risk prediction algorithm for recurrence of major depression

F.S. Then (Germany):
OP10 │ Exposure-dependent impact of specific mental work demands on dementia risk

B. O'Donoghue (Australia):
OP11 │ Neighbourhood characteristics and the rate of identification of young people at ultra-high risk for psychosis and risk of transition

U. Heilbronner (Germany):
OP12 │ Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study

D.B. Dwyer (Germany):
OP13 │ Personalised predictions of global functioning in individuals with serious mental illness across 17 independent sites

M. Ruggeri (Italy):
OP14 │ The GET UP research project in a 10 million inhabitant catchment area to implement public health perspectives that integrate epidemiology, genetics, environmental and brain morphofunctional variables in first episode psychosis

M.C. Viana (Brazil):
OP15 | The influence of exposure
to childhood adverse experiences on the early onset and persistence of
tobacco smoking
15:45-16:00 Coffee Break
 
16:00-17:00 ORAL PRESENTATIONS SESSION 4: Trauma and stigma   (16:00-16:45)  
Chair: M. Ruggeri (Italy

R. Kohn (USA):
OP16 │ Association of depression with PTSD in a 24-month longitudinal study following Hurricane Mitch

S. Tosato (Italy):
OP18 │ Early psychosis and childhood trauma: the effect of traumatic experiences on diagnosis, lifetime drug misuse, inflammatory biomarkers. Data from the GET UP Trial in a 10 million inhabitant catchment area

M.V. Markova (Ukraine):
OP19 │ Post-stressed disorders in servicemen who took part in the fighting: prevalence and expected consequences		 ORAL PRESENTATIONS SESSION 5:
The interface of physical and mental health
Chair: J.L.Wang (Canada)

A.S. Mueller-Stierlin (Germany):
OP20 │ Nutritional behaviour in patients with severe mental disorders

T.-C. Changchien (Taiwan):
OP21 │ Higher risk of developing depressive disorders in patients with gout: a nationwide population-based cohort study

D. Richter (Switzerland):
OP22 │ Physical health, health-related behaviour and healthcare utilisation of persons with severe mental illness: results from the Swiss Health Survey

G. Gal (Israel):
OP23 │ Health care for persons with severe mental illness and comorbid cardiovascular disorders: a case-control epidemiological study
17:30-18:30 WPA Section Meeting
 
Friday • 1 April 2016
MAIN HALL
(Amphitheater)
09:00-10:30 SESSION 4: Life perspectives (part B)
Chairs: M. Rietschel (Germany), V. Kovess (France)

  • S. Gau (Taiwan): Genetic studies in children and adolescents  
  • R. Bruffaerts (Belgium): Students’ mental health in Europe
  • G. Lewis (United Kingdom): Psychological vulnerability and risk of depression in adolescence
10:30-11:00 Coffee Break
11:00-12:30 SESSION 5: Use of administrative records and data mining in psychiatric epidemiology
Chairs: S. Gau (Taiwan) - T. Becker (Germany)

  • V. Kovess (France): Use of French national health insurance data for monitoring psychotropic drugs in children  
  • P. Qin (Norway): Utilisation of data from population registries for suicide research
  • H. Leonard (Australia): A bird’s eye view of autism research using data linkage in Western Australia
12:30-13:00
Closing Remarks - Future Meetings